My Top 5 Most Critical Clinical and Technology Needs in Temporary MCS

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Grant Support/Research Contract - Edwards Lifesciences; Medtronic; Boston Scientific Corporation; PulseCath BV; Daiichi-Sankyo/Elil Lilly and Company; Abbott
• Consultant Fee/Honoraria/Speaker's Bureau - Boston Scientific Corporation; Daiichi-Sankyo/Elil Lilly and Company; Abbott; JenaValve; ANteris; Siemens Healthineers; Amgen